Cipla share price

ABOUT Cipla

• Industry Biotechnology & Drugs
• ISIN INE059A01026
• BSE Code 500087
• NSE Code CIPLA

Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.

Cipla Management

• Umang Vohra Global Chief Executive Officer, Managing Director, Executive Director
• Ashish Adukia Global Chief Financial Officer
• Achin Gupta Chief Executive Officer - One India Business
• Paul Miller Chief Executive Officer - Cipla South Africa and Regional Head Africa and Access
• Nishant Saxena Chief Executive Officer - Emerging Markets and Europe
• Arunesh Verma Chief Executive Officer - North America
• Sneha Hiranandani Chief Information Officer
• Pradeep Bhadauria Global Chief Scientific Officer
• Rajendra Chopra Compliance Officer, Company Secretary
• Swapn Malpani Global Head Supply Chain